Partner Content Partner Content Sports Medicine Market will register 6% CAGR from 2019 to 20... Sports Medicine Market will exceed USD 9 bn by 2025
News AZ boasts phase 3 win for self-administered gMG drug Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
